Utility values in Japanese patients with exudative age-related macular degeneration

被引:13
|
作者
Yanagi, Yasuo [1 ]
Ueta, Takashi
Obata, Ryo
Iriyama, Aya
Fukuda, Takashi [2 ]
Hashimoto, Hideki [2 ]
机构
[1] Univ Tokyo, Sch Med, Dept Ophthalmol, Bunkyo Ku, Tokyo 1138655, Japan
[2] Univ Tokyo, Sch Publ Hlth, Dept Hlth Econ & Epidemiol Res, Tokyo, Japan
关键词
age-related macular degeneration; quality of life; utility value; PHOTODYNAMIC THERAPY; COST-EFFECTIVENESS; FELLOW EYES;
D O I
10.1007/s10384-010-0893-y
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
To investigate the utility values associated with visual loss due to age-related macular degeneration (AMD) in Japanese patients. Utility values in 48 Japanese patients with bilateral exudative AMD were measured using the time trade-off and standard gamble methods. The time trade-off method utility values correlated with the best-corrected visual acuity (BCVA) in the better-seeing eye. The estimated utility values according to the BCVA in the better-seeing eye were 0.534 (BCVA, 0.01-0.15), 0.574 (0.2-0.3), 0.613 (0.4-0.6), and 0.653 (0.7-1.0). The utility values obtained by the standard gamble method were not significantly correlated with BCVA in the betterseeing eye. The present results concur with those of previous studies showing that AMD causes a substantial decrease in patient utility values. The utility values obtained in the current study provide important information for use in cost-utility analysis of interventions for Japanese AMD patients.
引用
收藏
页码:35 / 38
页数:4
相关论文
共 50 条
  • [21] Angiographic findings in patients with exudative age-related macular degeneration
    Bermig, J
    Tylla, H
    Jochmann, C
    Nestler, A
    Wolf, S
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2002, 240 (03) : 169 - 175
  • [22] RESVEGA in exudative age-related macular degeneration
    Kubicz, A.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [23] Underdiagnosis of glaucoma in patients with exudative age-related macular degeneration
    Burak Mergen
    David J. Ramsey
    Eye, 2021, 35 : 3350 - 3357
  • [24] Macular buckle treatment of exudative age-related macular degeneration
    Recasens, MA
    Peyman, GA
    Conway, MD
    Peralta, E
    Kertes, PJ
    Greve, MDJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S319 - S319
  • [25] Macular thickness mapping in exudative age-related macular degeneration
    Shakoor, A
    Shahidi, M
    Blair, NP
    Gieser, JP
    Zelkha, R
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (01): : 44 - 48
  • [26] Presentation delay in patients affected with exudative age-related macular degeneration
    Haddad, WM
    Seres, A
    Coscas, G
    Soubrane, G
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2002, 240 (01) : 31 - 34
  • [27] Proteomics of Vitreous Humor of Patients with Exudative Age-Related Macular Degeneration
    Koss, Michael Janusz
    Hoffmann, Janosch
    Nguyen, Nauke
    Pfister, Marcel
    Mischak, Harald
    Mullen, William
    Husi, Holger
    Rejdak, Robert
    Koch, Frank
    Jankowski, Joachim
    Krueger, Katharina
    Bertelmann, Thomas
    Klein, Julie
    Schanstra, Joost P.
    Siwy, Justyna
    PLOS ONE, 2014, 9 (05):
  • [28] Laser treatment in 341 patients with exudative age-related macular degeneration
    Atmaca, Leyla
    Idil, Aysun
    Atmaca-Sonmez, Pelin
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2011, 4 (01) : 73 - 77
  • [29] Angiographic findings in patients with exudative age-related macular degeneration.
    Bermig, JH
    Tylla, H
    Jochmann, C
    Nestler, A
    Wolf, S
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S438 - S438
  • [30] Triamcinolone for occult exudative age-related macular degeneration
    Gillies, MC
    Simpson, JM
    Zhu, MD
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2006, 141 (01) : 228 - 228